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OBJECTIVE: The objective of this selective EBM review is to determine whether or not virtual 
reality training is effective in improving the quality of life for adults with Parkinson’s disease.  
 
STUDY DESIGN: A systematic review of two randomized controlled trials (RCTs) and one 
case series published between the years of 2017 and 2018.  
 
DATA SOURCES: All articles were published in English and were taken from peer-reviewed 
journals using CINAHL Plus. All articles were selected based on relevance to clinical question, 
evaluation of patient-oriented outcomes, and date of publication. 
 
OUTCOMES MEASURED: Each of the three articles analyzed the effects of virtual reality 
training on improving quality of life (QOL) for adults with Parkinson’s disease. The Parkinson’s 
Disease Questionnaire-39 (PDQ-39) and Parkinson’s Disease Questionnaire-8 (PDQ-8) were 
used to measure quality of life, which were reported as mean change from baseline. 
 
RESULTS: In the RCT conducted by Tollar et al., (J Cent Nerv Syst Dis. 2018;10: 
1179573518813541. doi:10.1177/1179573518813541) researchers found that PDQ-39 scores did 
improve following virtual reality rehabilitation (p<0.001). In the RCT by Gandolfi et al., (Arch 
Phys Med Rehabil. 2018;99(12):247-2484.e1. doi: //doi.org/10.1016/j.apmr.2018.05.007.) there 
was also significant improvement in the PDQ-8 scores before and after the intervention of virtual 
reality training (p<0.001). However, the case series performed by Souza et al. (Fisioterapia em 
Movimento. 2018;31. doi:10.1590/1980-5918.031.ao12.) showed insignificant findings in the 
overall PDQ-39 scores after the intervention was implemented (p=0.135). 
 
CONCLUSIONS: The three studies evaluated in this review provided inconclusive evidence on 
whether or not virtual reality training is effective in improving quality of life for adults with 
Parkinson’s disease. Tollar et al. (J Cent Nerv Syst Dis. 2018;10: 1179573518813541. 
doi:10.1177/1179573518813541) and Gandolfi et al. (Archives of Physical Medicine and 
Rehabilitation. 2018;99(12):247-2484.e1. doi: //doi.org/10.1016/j.apmr.2018.05.007.) 
demonstrated a statistically significant improvement in quality of life whereas Souza et al. 
(Fisioterapia em Movimento. 2018;31. doi:10.1590/1980-5918.031.ao12.) showed no 
significance. Due to the conflicting results and limitations mentioned in each study, further 
investigation is warranted to more effectively evaluate the effects of virtual reality rehabilitation 
in improving quality of life for adults with Parkinson’s disease. 
 
KEY WORDS: Parkinson’s, virtual reality, physical therapy
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INTRODUCTION 
Parkinson’s disease is a progressive neurodegenerative disorder that occurs due to 
deterioration of dopamine in the substantia nigra and degeneration of the basal ganglia, which 
leads to a loss in control of voluntary movements. Although Parkinson’s disease has 
conventionally been identified as a type of movement disorder, it is now considered a complex 
disorder with additional neuropsychiatric and nonmotor manifestations.1 The progressive decline 
of motor and cognitive functions can consequently result in adverse effects on an individual’s 
independence and quality of life (QOL).2  
As the second most-common neurodegenerative disorder in the US, the prevalence of 
Parkinson’s disease in the US is 0.3% in the general population, 1-2% in persons over age 65, 
and 4-5% in persons over age 85.1 The national economic burden of this condition is estimated to 
be above $14.4 billion with the cost at approximately $22,800 per patient.1 In 2010, the 
population of Parkinson’s disease patients incurred nearly 1.9 million hospital inpatient days and 
1.26 million physician office visits.1 As the number of people living with neurological conditions 
like Parkinson’s disease steadily rises with age, it is projected that the burden of the disease will 
grow with the aging population. 
It is well understood that the signs and symptoms of Parkinson’s disease are 
predominately due to the loss of dopaminergic neurons in the midbrain. This disease is 
characterized primarily by motor impairments including resting tremor, bradykinesia, rigidity, 
and abnormal gait. Nonmotor clinical manifestations include, but are not limited to, cognitive 
changes, psychosis, depression, anxiety, sleep disturbances, autonomic dysfunction, olfactory 
issues, and gastrointestinal disturbances. As the diverse clinical features of the disease can vary 
greatly between patients, it is important for healthcare clinicians to recognize the characteristic 
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signs and symptoms in order to properly diagnose the condition and provide symptomatic 
treatment early on to prevent mobility-related disability and comorbidities.3 
While it is it is believed that Parkinson’s disease is a multifactorial neurodegenerative 
process that occurs from a combination of factors such as aging, neuronal susceptibility, genetic 
predisposition, and environmental exposures, the exact cause of disease is unknown.4 With that 
being said, there is no standard treatment approach for patients.1 Nearly all available treatments 
can provide symptomatic relief, however these interventions do not reverse the effects of the 
disease. As mid-level practitioners, physician assistants working in the hospital and outpatient 
setting must integrate various treatment modalities into their plan of care to help relieve 
symptoms and maintain quality of life for patients. 
Management of this condition with nonpharmacologic, pharmacologic, and/or surgical 
therapy must be personalized to the needs of the individual patient. Non-pharmacologic 
intervention involves lifestyle management with exercise, diet modifications, use of assisted 
walking devices, speech therapy, and occupational therapy. Pharmacologic therapy is considered 
the first-line treatment option for PD, which includes levodopa, dopamine agonists, MAO-B 
inhibitors, and amantadine.4 Surgical options, such as pallidotomy and deep brain stimulation, 
can be utilized in advanced disease refractory to pharmacological treatment.4  
As mentioned previously, Parkinson’s disease patients can suffer from motor 
impairments, such as postural instability and gait disturbances, which can adversely affect their 
level of independence and quality of life.6 As postural instability is known to be refractory to 
medications, rehabilitation is especially valuable in the management of Parkinson’s disease.3 
Virtual reality therapy is an innovative approach to rehabilitation that is aided by gaming 
technology in order to provide multisensory and complex exercise stimuli to participants. This 
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therapy allows patients to engage in virtual reality scenarios by using their body movements to 
control and play video games, which has been proven to be feasible and effective in neurological 
conditions.3 It is thought that virtual reality training can help improve the quality of life for 
Parkinson’s disease patients by promoting positive effects on posture and gait.  
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not “Is virtual 
reality training effective in improving the quality of life for adults with Parkinson’s disease?” 
METHODS 
 The articles utilized for this systematic review were found online via CINAHL Plus by 
using the following key words: Parkinson’s, virtual reality, and physical therapy. Each study was 
published in English in a peer-reviewed journal between the years of 2017 and 2018. These 
sources were selected based on their relevance to the clinical question and evaluation of patient-
oriented outcomes (POEMs). Inclusion criteria for the studies included studies published after 
2016. Exclusion criteria for the studies included studies published in 2016 or earlier. Summary of 
statistics used in this review to determine clinical significance include p-value and mean change 
from baseline.  
The data sources of this systematic review specifically focused on the population of 
adults with Parkinson’s disease. The three studies that were utilized for this review include two 
randomized controlled trials (RCTs) and one case series. Each RCT compared the intervention 
group of virtual reality training to two different control groups: no physical intervention and in-
clinic balance training. The case series did not compare the intervention to any control group. 
The outcome that was measured in all three studies was quality of life. 
 
Le | Virtual Reality Training in Parkinson’s   4 
Table 1. Demographics and Characteristics of Included Studies 
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OUTCOMES MEASURED 
The patient-oriented outcome that was measured in each article was quality of life. Souza 
et al. used the Parkinson Disease Questionnaire-39 (PDQ-39), a self-reported survey of 39 
questions that assessed 8 domains: mobility, daily life activities, emotional state, stigma, social 
support, cognition, communication, and body discomfort. Each domain was scored from 0 to 
100, with a lower score representing a better perception of quality of life. Each participant 
completed the PDQ-39 before treatment, immediately after treatment, and 30 days after 
treatment, which was presented as mean differences before and after treatment. Tollar et al. also 
utilized the PDQ-39 to measure quality of life scores in both groups before and after treatment. 
The results of the PDQ-39 were reported as mean differences, with a change of 4.7 considered as 
clinically significant.6 Gandolfi et al. used the Parkinson Disease Questionnaire-8 (PDQ-8) to 
measure quality of life. The participants of this study completed the self-reported survey before 
treatment, after treatment, and 1 month following treatment. The quality of life scores, presented 
as mean values, were compared between the tele-rehabilitation group and the in-clinic 
rehabilitation group, and also within each group overtime.  
RESULTS 
 The case series performed by Souza et al. consisted of 11 participants between the ages of 
48 to 76 years old, who had a diagnosis of Parkinson’s disease with stage 1 to 3 classification on 
the Hoehn and Yahr Scale.2 This study, completed at the University of Sao Paulo in Brazil, 
selected participants based on convenience for the study and inclusion criteria of normal or 
corrected visual and auditory acuity, no previous involvement with Kinect system, and no 
involvement in an exercise program within the last 2 months. Participants were excluded if they 
presented with any cardiorespiratory, orthopedic, or other detectable neurologic disability, such 
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as dementia or clinical signs of dyskinesia, due to the possibility that any clinical impairments 
from these conditions might have negatively affected their ability to perform standing exercises. 
 In this study by Souza et al., each subject participated in a total of 14 one-hour sessions 
(twice a week for 7 weeks) where they played 4 different games of Kinect Adventures on a 
virtual-reality system via a X-Box gaming device.2 The games, selected based on motor and 
cognitive demands, were completed 5 times with assistance by a physiotherapist. Patients were 
not involved in any other type of rehabilitation during the period of the study. There were no 
reports on safety, tolerability, or adverse effects of treatment. 
The PDQ-39 assessed quality of life by evaluating the mean scores of 8 different domains 
pre- and post- treatment with a p-value of <0.05 considered to be clinically significant.2 As 
presented in Table 2, the only domain that demonstrated a substantial improvement was the 
activities of daily living, in which there was a significant decrease of 8.7 in the pre-treatment 
score to the 30-day post-treatment score (p<0.023).2 This improvement in daily activities was 
attributed to the enhancement of postural control and cognition with the virtual reality games.2 
The other seven domains plus the total PDQ-39 score demonstrated no significant change in 
mean values pre- and post-treatment (p>0.05).2 Based on the results for all of the domains, 
besides daily activities, the mean difference was lower than the value defined by the author. 
Table 2. Mean (SD) Change in QOL and P-Values in a Study Conducted by Souza et al.2 
Domain Pre-Intervention 
Mean (SD) 
30 Days Post-Intervention 
Mean (SD) 
P-Value 
Mobility 23.9 (27.5) 10.9 (9.6) 0.328 
Activities of Daily Living* 29.9 (22.7) 21.2 (21.8) 0.023 
Emotional Well Being 22.0 (22.8) 21.2 (15.0) 0.794 
Stigma 10.2 (15.6) 11.9 (17.3) 0.692 
Social Support 65.2 (5.0) 68.9 (5.4) 0.135 
Cognition 21.0 (13.8) 18.2 (15.9) 0.248 
Communication 22.7 (25.8) 18.2 (21.0) 0.446 
Body Discomfort 30.3 (23.9) 34.8 (25.8) 0.682 
Total 27.0 (11.9) 21.8 (8.2) 0.135 
*P-value <0.05 is significant 
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 The multisite, single-blind RCT completed by Gandolfi et al. involved patients with 
Parkinson’s disease and modified Hoehn and Yahr stages 2.5-3.3 Initially, there were 135 
outpatients at 4 different neurorehabilitation units located in Veneto who were assessed for 
eligibility. Inclusion criteria to participate included age >18 years old, modified Hoehn and Yahr 
stages of 2.5-3, steady medication usage in last month, ability to perform postural transfer and 
ability to remain standing posture for 10 minutes, and presence of a caregiver. Patients were 
excluded if they had any cardiovascular, orthopedic, or otovestibular disorders; visual or 
neurological disorders; severe dyskinesia or severe on-off fluctuations; Mini Mental State 
Examination score <24/30; or depression. Of the original 135 patients, 26 patients were excluded 
due to criteria stated above, 13 declined to participate, and 20 faced technological issues 
preventing their participation. 
 The remaining 76 subjects in the study conducted by Gandolfi et al. were randomly 
assigned by a computer-generated random number table into either the in-home virtual reality 
tele-rehabilitation (TeleWii) group or the in-clinic sensory integration balance training (SIBT) 
group.3 Two patients in the TeleWii group and four patients in the SIBT group withdrew from 
the study due to medical reasons or transportation issues. Both groups participated in 21 sessions 
of 50-minute rehabilitation. The TeleWii group consisted of balance exercises using the 
Nintendo Wii Fit System, which was supervised by a physiotherapist. Under instruction and 
support of a physical therapist, the SIBT group participated in 10 exercises aimed at improving 
postural stability. Patients were not permitted to receive any other type of rehabilitation during 
the period of the study. The study reported that there were no adverse events of either treatment, 
however there was no information provided regarding safety or tolerability. 
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 In this study, mean values and standard deviation were used as descriptive statistics to 
measure PDQ-8 scores before and after treatment and the level of significance was established at 
p<0.025 for post hoc analysis.3 As shown in Table 3, both groups demonstrated an overall 
improvement in outcomes measured before and after treatment.3 The TeleWii group had a 
decrease of 4.9 from a pre-treatment mean of 30.72 to a post-treatment mean of 25.82 (p<0.001), 
while the in-clinic group had a decrease of 6.62 from a pre-treatment mean of 30.53 to a post-
treatment mean of 23.91 (p=0.016).3 However, there was no significant between-group 
difference in PDQ-8 outcomes as measured by the post hoc analysis (p>0.025).3 
Table 3. Mean (SD) Change in QOL and P-Values in a Study Conducted by Gandolfi et al.3 
 Pre-Intervention 
Mean (SD) 
1 Month Post-Intervention 
Mean (SD) 
Post Hoc Analysis 
P-Value 
Within Groups 
Post Hoc Analysis 
P-Value 
Within Groups 
TeleWii** 30.72 (15.54) 25.82 (14.89) <0.001 >0.025 
In-Clinic** 30.53 (16.04) 23.91 (13.20) 0.016 
**For post hoc analysis, p-value <0.025 is significant  
 
The RCT conducted by Tollar et al. involved patients with a diagnosis of Parkinson’s 
with Hoehn and Yahr stages 2-3.6 Initially, 72 subjects were found by referrals from neurologists 
in the area and by calling patients in the hospital’s database. Prior to the study, patients were 
subjected to preliminary screening which included a full neurological examination, a gait and 
posture examination, and an evaluation of cognitive function. Additionally, participants were 
instructed to remain on levodopa medication therapy in order to lessen motor symptoms. Patients 
were excluded if they presented with cognitive deficits, depression, severe cardiovascular 
disease, uncontrolled DM, history of stroke, traumatic brain injury, seizure disorder, or current 
involvement in an exercise program or deep brain stimulation. Exclusion criteria was instilled as 
these factors could have possibly altered motor ability and therefore, response to treatment. Of 
the 72 eligible participants, three were excluded for reasons stated above and five declined to 
participate. 
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The subjects in the study conducted by Tollar et al. were randomly allocated into a no 
physical intervention control group or a high-intensity agility intervention group.6 Of the 
remaining 64 patients who were randomly allocated to either the control or intervention group, 9 
patients were excluded as they refused to be tested at baseline and withdrew from the study. 
Patients in the intervention group underwent 15 one-hour sessions over 3 weeks, which included 
4 parts that focused on postural instability and motor deficits: a warm-up, sensorimotor and 
visuomotor agility training, sensorimotor agility training using virtual reality modules, and a 
cool-down. These sessions were offered in the hospital’s physical therapy gym under supervision 
of up to 3 physical therapists who implemented strict safety guidelines. Compliance was 
measured through an attendance and symptom log, which showed 100% adherence to the 
exercise program. The study did not provide reports on safety, tolerability, or adverse effects. 
 In this study, the results of the PDQ-39 were reported as mean differences, with a change 
of 4.7 considered to be clinically significant and a level of clinical significance set at P<0.05.6 As 
shown in Table 4, the intervention group improved in PDQ-39 outcomes before and after 
treatment, while the control group did not improve.6 In the high-intensity agility group, there was 
a 6.6-point decrease from the pre-intervention score of 30.0 to the post-intervention value of 23.4 
(p<0.001).6 In comparison, the control group had a 0.2 increase from the pre-intervention score 
of 30.6 and a post-intervention score of 30.8 (p>0.05).6 The difference between the mean values 
of the intervention group before and after treatment was large and exceeded the 4.7-point 
threshold, indicating a clinically significant reduction in quality of life.  






Intervention* 30.0 (8.3) 23.4 (7.2) <0.001 
Control 30.6 (15.0) 30.8 (13.8) >0.05 
*P-value <0.05 is significant 
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DISCUSSION 
The results of this study were conflicting as two studies presented statistically significant 
results and one study had insignificant results. In the case series by Souza et al., there was no 
statistical significant reduction in PDQ-39 scores besides in the daily activities domain.2 
However, it has been shown that this specific domain is strongly associated with improving the 
health of patients with Parkinson’s disease.2 In the RCT by Gandolfi et al., there was no 
significant change between groups when comparing quality of life scores in the virtual reality 
balance training to in-clinic balance training, but there were significant changes in the two 
groups overtime.3 Nonetheless, this is clinically significant as the quality of life of PD patients 
can improve regardless of treatment modality. The results of Tollar et al. showed significant 
improvement in PDQ-39 outcomes in the intervention group, which were attributed to 
improvement in motor symptoms.6 
Each study acknowledged various limitations that may have affected the generalizability 
and significance of the results. In the case series by Souza’s et. al, the small sample size, lack of 
a control group, and great variability in disease stages of the participants may have limited the 
outcomes of this study.2 Individuals in early stages of the disease without disabling symptoms 
had a good perception of their quality of life prior to intervention, which may have limited their 
ability to achieve significant improvements in their scores after treatment.2 Limitations in the 
study conducted by Tollar et al. include lack of follow up post treatment and lack of 
measurement of physical activity and diet modifications during treatment.6 Additionally, Tollar 
et al. proposed that the Hawthorne effect may have swayed the results as participants could have 
improved just from treatment and close observation.6 
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While virtual reality programs have proven to be feasible and effective in improving 
postural control, gait, and cognition in several neurological conditions, there are limitations of 
this treatment. One limitation is the safety of virtual reality programs in patients due to potential 
hazards of participation.3 It has been reported that virtual reality can result in adverse symptoms 
like sickness, dizziness, and headache.7 Another limitation posed by Tollar et al. are policy issues 
regarding reimbursement of therapy.6 Although virtual reality training has been proposed as a 
cost-effective treatment, the cost of this new technology is high.7 Further investigation is 
required to determine the costs associated with this novel rehabilitation program. 
CONCLUSION 
 Based on the results of the two RCTs and one case series reviewed in this study, the 
evidence is conflicting on whether or not virtual reality therapy is effective in improving quality 
of life for adults with Parkinson’s disease. The case series by Souza et al. did not have significant 
improvement in scores, which may have been influenced by the limitations of the study.2 
However, in the two RCTs, there was a clinically meaningful reduction in PDQ scores in the 
virtual reality intervention group, which holds potential for this therapy in the future.3,6 Further 
studies are warranted with a larger variety of control groups, larger sample sizes, and longer 
duration of treatment and follow up. Additionally, future research on treatment safety, adverse 
effects, and tolerability is critical. As the projected burden of chronic conditions like Parkinson’s 
disease continues to grow, there is an increased need for innovative treatment options to prevent, 
delay onset, and alleviate symptoms of these conditions. Although virtual reality therapy opens 
new opportunities for benefiting Parkinson’s disease patients, more rigorously designed 
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